Azulfidine and condition aggravated Patient Reports February 11, 2012

Azulfidine Side Effects Report #4817549-X
Azulfidine side effect was reported by a Physician from JAPAN on Oct 20, 2005. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis  and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: aplastic anaemia, arthralgia, bone marrow failure, condition aggravated, hepatic function abnormal. Azulfidine dosage: unknown. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #4577966-2
Azulfidine side effect was reported by a Physician from on Jan 27, 2005. Female patient, 63 years of age, was diagnosed with rheumatoid arthritis  and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: condition aggravated, infection , interstitial lung disease, nasopharyngitis. Azulfidine dosage: 500 MG ORAL. During the same period patient was treated with DICLOFENAC. Patient died on 10/31/2004.

Azulfidine Side Effects Report #4594016-2
Azulfidine side effect was reported by a Physician from on Feb 08, 2005. Female patient, 63 years of age, was diagnosed with rheumatoid arthritis  and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: condition aggravated, infection , interstitial lung disease, nasopharyngitis. Azulfidine dosage: 500 MG (500 MG, 1 IN 1D), ORAL. During the same period patient was treated with DICLOFENAC, ETODOLAC, INDOMETHACIN. Patient was hospitalized. Patient died on 10/31/2004.

Azulfidine Side Effects Report #4645362-5
Azulfidine side effect was reported by a Physician from on Apr 12, 2005. Female patient, 63 years of age, was diagnosed with rheumatoid arthritis  and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, nasopharyngitis. Azulfidine dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ETODOLAC, INDOMETHACIN, DICLOFENAC, METHYLPREDNISOLONE. Patient was hospitalized. Patient died on 10/31/2004.


Azulfidine Side Effects Report #4585154-9
Azulfidine side effect was reported by a Consumer or non-health professional from on Jan 31, 2005. Male patient, 61 years of age, weighting 170.0 lb, was diagnosed with rheumatoid arthritis  and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: chromaturia, colitis, condition aggravated, dehydration, pancreatitis, rheumatoid arthritis , stress . Azulfidine dosage: 4000 MG (2000 MG, 1 IN 2 D); ORAL. During the same period patient was treated with PREDNISONE, AZATHIOPRINE, CETIRIZINE, MONTELUKAST. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #5106177-7
Azulfidine side effect was reported by a Physician from JAPAN on Sept 01, 2006. Female patient, 33 years of age, weighting 110.2 lb, was diagnosed with rheumatoid arthritis  and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic function abnormal, liver disorder, rheumatoid arthritis . Azulfidine dosage: 1000 MG (500 MG, 2 IN 1D); ORAL. During the same period patient was treated with FOSAMAX, VOLTAREN, SHIOSOL. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #4609349-0
Azulfidine side effect was reported by a Consumer or non-health professional from on Feb 28, 2005. Female patient, 32 years of age, weighting 99.21 lb, was diagnosed with rheumatoid arthritis , ill-defined disorder and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: arthralgia, condition aggravated, conjunctivitis, erythema, headache , ocular hyperaemia, oral pruritus. Azulfidine dosage: 500 MG (1 IN 1 D), ORAL. During the same period patient was treated with TEPRENONE. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #5655993-1
Azulfidine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 26, 2008. Male patient, weighting 158.7 lb, was diagnosed with rheumatoid arthritis  and was treated with Azulfidine. After drug was administered, patient experienced the following side effects: condition aggravated, eczema , gastrointestinal perforation, petechiae. Azulfidine dosage: unknown. During the same period patient was treated with ETANERCEPT, LIMAPROST, FOLIAMIN, PREDNISOLONE, TEPRENONE, ETODOLAC, PYRIDOXAL PHOSPHATE, BUCILLAMINE. Patient was hospitalized. Patient died on 12/08/2007.